STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
32 hedge funds and large institutions have $94.2M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 7 closing their positions.
Holders
32
Holders Change
-4
Holders Change %
-11.11%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Morgan Stanley
New York
|
$1.02M |
2 |
SC
2
Samlyn Capital
New York
|
$12.2M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$682K |
4 |
![]()
4
JPMorgan Chase & Co
New York
|
$195K |
5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$979K |